secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2023-03-20T23:59:59+00:00
Accession:  0001654954-23-003181
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dermata Therapeutics closes $5.0M public offering of common stock and warrants
------------------------------------------------------------------------------

- Gross proceeds of $5.0M from offering of 1.62M shares (or pre-funded warrants) plus Series A/B warrants at $2.82 exercise price.
- Net proceeds approx. $4.2M; H.C. Wainwright acted as placement agent with 7.0% cash fee.
- Existing warrants for 235,849 shares amended: exercise price lowered from $21.20 to $2.82, expiry extended to 5 years.
- Offering closed March 20, 2023; 60-day lock-up on further equity issuance and one-year variable-rate transaction ban.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000165495423003181/0001654954-23-003181-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000165495423003181/drma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-23-003181

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer